Quantum Capital Management (California)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$0 Hold
50
– – ﹤0.01% 282
2020
Q2
$1K Hold
50
– – ﹤0.01% 303
2020
Q1
$0 Hold
50
– – ﹤0.01% 320
2019
Q4
$0 Hold
50
– – ﹤0.01% 327
2019
Q3
$0 Buy
+50
New +$383 ﹤0.01% 332
2013
Q4
– Sell
-150
Closed -$6K – 229
2013
Q3
$6K Buy
+150
New +$5.85K ﹤0.01% 187

Other funds holding TEVA

Quantum Capital Management (California)'s TEVA Position: Q3 2020 in Review

Quantum Capital Management (California) held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q3 2020 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #282.

Quantum Capital Management (California) first reported a position in TEVA in Q3 2013 and has held it in 6 quarters since. The position peaked at $6K in Q3 2013. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Quantum Capital Management (California) held 50 shares of Teva Pharmaceutical Industries Limited worth $0 as of Q3 2020.
  • Quantum Capital Management (California) left its Teva Pharmaceutical Industries Limited share count unchanged in Q3 2020.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #282 holding.
  • Quantum Capital Management (California) first reported a position in Teva Pharmaceutical Industries Limited in Q3 2013 and has held it in 6 quarters since.
  • Quantum Capital Management (California)'s Teva Pharmaceutical Industries Limited position peaked at $6K in Q3 2013.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.